BioSoft Integrators Revenue and Competitors
Estimated Revenue & Valuation
- BioSoft Integrators's estimated annual revenue is currently $2M per year.
- BioSoft Integrators's estimated revenue per employee is $155,000
Employee Data
- BioSoft Integrators has 13 Employees.
- BioSoft Integrators grew their employee count by -43% last year.
BioSoft Integrators's People
Name | Title | Email/Phone |
---|
BioSoft Integrators Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is BioSoft Integrators?
Your one stop shop for Informatics, Analysis, High Performance Computing and Automation/Integration. BioSoft Integrators, the leading provider of vendor neutral Informatics and automated products, will guide you using its proven methodologies to properly scale your laboratory: LIMS High Performance Computing Clusters Laboratory Instrument Systems Data Warehousing Scientific Data Management Systems (SDMS) Data Archival ELN Enterprise Resource Planning (ERP Systems Integration) Custom Automation User Interfacing and Programming
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
-43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioSoft Integrators News
BioSoft Integrators: Optimizing Next-Gen Sequencing Data Analysis · OvrClk: Delivering High - Performance Workloads at the Edge · R Systems NA, Inc.:
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.6M | 15 | 0% | N/A |
#2 | N/A | 16 | 78% | N/A |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $2.8M | 18 | 6% | N/A |
#5 | N/A | 20 | -33% | N/A |